| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Rho-associated protein kinase 1 [17-535] |
|---|
| Ligand | BDBM362926 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Inhibition Assay |
|---|
| IC50 | >10000000±n/a nM |
|---|
| Citation |  Glick, GD 1,4-benzodiazepone-2,5-diones and related compounds with therapeutic properties US Patent US9849138 Publication Date 12/26/2017 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Rho-associated protein kinase 1 [17-535] |
|---|
| Name: | Rho-associated protein kinase 1 [17-535] |
|---|
| Synonyms: | ROCK1 | ROCK1_HUMAN | Rho GDP-dissociation inhibitor 1 | Rho Kinase 1 | Rho-associated protein kinase 1 (ROCK1) |
|---|
| Type: | Protien |
|---|
| Mol. Mass.: | 60345.48 |
|---|
| Organism: | Homo Sapiens (Human) |
|---|
| Description: | aa 17-535 |
|---|
| Residue: | 519 |
|---|
| Sequence: | LLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDY
EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV
VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH
RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG
RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF
LTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKG
EEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLE
EQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRIN
EYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQL
|
|
|
|---|
| BDBM362926 |
|---|
| n/a |
|---|
| Name | BDBM362926 |
|---|
| Synonyms: | US9849138, 2 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C23H20ClN3O2 |
|---|
| Mol. Mass. | 405.877 |
|---|
| SMILES | CN1c2ccc(Cl)cc2C(=O)N[C@@](C)(Cc2ccc(cc2)-c2ccncc2)C1=O |r| |
|---|
| Structure | 
|
|---|
Search and Browse
